Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Articles

Page Path
HOME > Intest Res > Volume 12(2); 2014 > Article
Review
Focused Review: Gut and Basic Research
Lipopolysaccharide: Basic Biochemistry, Intracellular Signaling, and Physiological Impacts in the Gut
Sang Hoon Rhee
Intestinal Research 2014;12(2):90-95.
DOI: https://doi.org/10.5217/ir.2014.12.2.90
Published online: April 29, 2014

Division of Digestive Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.

Correspondence to Sang Hoon Rhee, Division of Digestive Diseases, David Geffen School of Medicine, University of California Los Angeles, MRL 1240, 675 Charles E. Young Dr., South, Los Angeles, CA 90095, USA. Tel: +1-310-794-5148, Fax: +1-310-825-3542, shrhee@mednet.ucla.edu
• Received: February 22, 2014   • Revised: February 27, 2014   • Accepted: March 1, 2014

© Copyright 2014. Korean Association for the Study of Intestinal Diseases. All rights reserved.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

prev next
  • 12,210 Views
  • 128 Download
  • 102 Web of Science
  • 110 Crossref
  • Lipopolysaccharide (LPS), a main constituent of Gram-negative bacterial membrane, specifically activates Toll-like receptor 4, leading to the production of pleiotropic cytokines/chemokines which in turn regulate inflammatory and innate and subsequent adaptive immune responses. Given that human gut harbors a large collection of commensal bacteria, LPS released by gut microbes is able to make the great impact on gut homeostasis through the intracellular signaling pathways engaged by host-microbial interaction. Emerging evidence indicates that LPS in the gut has a potency to elicit the pathogenesis of intestinal inflammatory diseases such as inflammatory bowel disease and necrotizing enterocolitis. In this review, we discuss the current understanding of the basic biochemistry of LPS, LPS-induced intracellular signaling, and physiological impacts of LPS in the intestine.
Lipopolysaccharide (LPS) is a major component in the outer monolayer of the outer membrane of most Gram-negative bacteria so as to work like a tight shield (Fig. 1). It consists of unique molecules, such as lipid A, core oligosaccharide, and O-specific oligosaccharide chain (Fig. 2).1 Lipid A is a β, 1-6 linked disaccharide of glucosamine which is acylated with R-3-hydroxymyristate at positions 2, 3, 2', and 3', and phosphorylated at positions 1 and 4'. The two R-3-hydroxy-acyl groups of non-reducing glucosamine are further esterified with laurate and myristate. However, various molecular species of lipid A are found in pathogenic gram negatives (Fig. 3). This region gives rise to biological responses that LPS induces.1,2 It is noteworthy that lipid A with six lipid chains executes full functional activity, whereas those with five lipid chains have ~100 fold less activity, and those with four lose agonistic activity. Core region of LPS is divided into the inner core and the outer core. The former part is linked to the lipid and the latter is connected to the O-specific chain. The 6' position of lipid A is glycosylated with eight-carbon sugar, 3-deoxy-D-manno-octulosonic acid (KDO). Found in most endotoxins, KDO is believed to be a potential target of therapy against LPS-associated diseases. Other core sugars include L-glycero-D-manno-heptose, glucose, galactose, and N-acetylglucosamine.2,3 The O-specific chain generally consists of 20-40 repeating saccharides, but the composition is usually different for each bacterial species. This variable region elicits production of different antibodies. Although these three segments give rise to highly complex LPS structure, lipid A is sufficient to evoke the signaling events of LPS. The entire lipid component of LPS molecule, however, is required for optimal activity. With this in mind, the individual elements appear to combine into a three-dimensional shape to facilitate interaction with the host cells.2,3
LPS itself is not intrinsically harmful. Instead, it acts by inducing myeloid and/or non-myeloid cells to produce a number of proinflammatory cytokines, such as tumor necrosis factor, interleukins, inducible nitric oxide synthase, and cyclooxygenase-2, which lead to fever, inadequate organ perfusion, multi-organ failure, and death observed in septic shock.4,5,6 With this in mind, LPS is a potent activator of the inflammatory responses and even minute amounts of LPS in the blood by bacterial infection are sufficient to induce potent inflammatory responses.
LPS is recognized by the core receptor complex composed of LPS-binding protein (LBP), CD14, Toll-like receptor 4 (TLR4), and MD-2. LBP is 60 KDa glycoprotein that binds to lipid A of LPS, leading to LPS-LBP complex.7 CD14 acts as a membrane receptor for LPS-LBP complex, and binding of LPS to CD14 is enhanced by LBP. CD14 is a 55 KDa protein in myeloid cells such as monocytes/macrophages. There are two types of CD14, a soluble form (sCD14) and a membrane bound form (mCD14) which is a glycosylphosphatidylinositol-anchored membrane protein, but sCD14 lacks the glycosylphosphatidylinositol-anchor.8 mCD14, however, does not have transmembrane domain to transduce LPS signaling from extracellular environment to cytosol. MD-2 is an extracellular protein responsible for LPS binding and associated with the extracellular domain of TLR4. Transfer of LPS from mCD14 to TLR4-MD-2 complex induces multimerization of the receptor complex, resulting LBP/CD14/TLR4/MD-2 complex in the plasma membrane. Subsequently, LPS bound receptor complex triggers an intracellular signaling cascade. So far, ten members (TLR1 to TLR10) of the TLR family recognizing a wide variety of microbial products have been identified in humans. Among various TLR members is TLR4 which specifically recognizes LPS and mediates LPS-induced intracellular signaling pathways.
Decreased sensitivity to the proinflammatory and lethal effects of LPS were observed in the C3H/HeJ mouse strain.9 C3H/HeJ mice were naturally resistant to LPS preparations from Salmonella typhosa 0-901 and Escherichia coli 0127:B8, tolerating 20 and 38 times the medial lethal dose, respectively, for other C3H sublines that are normally responsive to LPS. In addition, LPS or Lipid A is not cytotoxic in vitro for macrophages from C3H/HeJ, but directly cytotoxic for those from LPS-responsive mice.10 It was also suggested that B lymphocytes from C3H/HeJ mice were specifically hyporesponsive to LPS, but responded normally to other B-cell stimulators.11 LPS responses were also defective in T lymphocytes and fibroblasts from C3H/HeJ mice.12 These results indicated that C3H/HeJ mice were hyporesponsive to LPS. Genetically, it was demonstrated that these LPS hyporesponsive mouse strains have a defective Lps allele (Lpsd) in chromosomal assignment of the Lps locus on chromosome 4, while a normal Lps allele (Lpsn) is characteristic of most inbred mouse strains that are LPS responsive.13 Two other LPS hyporesponsive mouse strains have been identified, C57BL/10ScCr and its progenitor C57BL/10ScN (also known as C57BL/10ScNCr). It was identified that the LPS hyporesponsive phenotype of C57BL/10ScCr was due to a mutation at the Lps locus, and crosses between C57BL/10ScCr (Lpsd) and C57BL/10Sn (Lpsn) have yielded only the high-LPS responder phenotype, indicating that this Lps mutation is recessive.14
Using several techniques including cDNA selection, genomic sequencing or randomly-subcloned DNA, and comparative mapping, a candidate for Lps gene product was identified and assigned as TLR4.15,16 It was also determined that LPS hyporesponsive C57BL/10ScCr and C57BL/10ScNCr mouse strains do not transcribe TLR4 due to a chromosomal deletion in Lps gene, resulting in LPS tolerance.16 The mouse TLR4-encoding gene contains one open reading frame of 2,505 nucleotides, predicted to encode a protein of 835 amino acids. This protein consists of an extracellular domain formed by a tandem arrangement of 22 leucine-rich repeat motifs connected by a single transmembrane domain to an intracellular signaling domain that shares homology with the cytosolic region of interleukin-1 receptor (IL-1R). Furthermore, nucleotide sequencing of the entire coding region of TLR4-encoding gene in endotoxintolerant C3H/HeJ mice revealed a single missense mutation consisting of a C to A transversion at nucleotide 2,135, resulting in a substitution of proline for histidine at codon 712 (Tlr4 [P712H]) within the signaling domain of TLR4. This missense mutation within the cytoplasmic domain of TLR4 averts LPS-induced signaling, rendering the mouse non-responsive to LPS.6,15 These findings explained how C3H/HeJ mice are hyporesponsive to LPS. Identification of distinct independent mutations of the same gene in these strains of endotoxin-tolerant mice provides compelling evidence that TLR4 encoded by Lps gene is the receptor to LPS.15,16
TLR proteins are ligand-stimulated receptor molecules that elicit their pleiotropic effects through activation of the transcription factors nuclear factor kappaB (NFκB) and activator protein-1 (AP-1). Given that the cytoplasmic domain of TLR proteins is homologous to that of IL-1R, these regions are referred to as Toll/IL-1R (TIR) domain. Thus, the investigation of the cellular mechanism from TLR activation was approached on the basis of understanding IL-1R signaling pathway. When microbial products encounter their specific TLRs, TLRs recruit a single or a combination of adaptor molecule(s) containing TIR domain to its cytoplasmic TIR domain. At least four adaptors such as myeloid differentiation factor 88 (MyD88), MyD88 adaptor-like/TIR domain-containing adaptor protein (Mal/TIRAP), TIR domain-containing adaptor-inducing IFN-β (TRIF), and TRIF-related adaptor molecule (TRAM) have been identified in TLR-mediated signaling pathways. After binding to the cytoplasmic TIR domain of TLRs, these adaptor molecules associate with IL-1R-associated kinases (IRAKs) to mediate the signaling to a member of tumor necrosis factor receptor-associated factor (TRAF) family (e.g. TRAF6). Thereby, TLR-induced signaling leads to activation of IKKs and MAPKs to activate transcription factors such as NFκB, AP-1, and interferon-regulatory factors, followed by inducing a pleiotropic gene expression involved in immune and inflammatory responses.17
LPS interacts with LBP to form LPS-LBP complex which binds to CD14. However, CD14 can not mediate LPS signaling through the cell membrane, because CD14 does not have a transmembrane domain. Thus, it is believed that CD14 functions as the co-receptor for TLR4.18 Furthermore, LPS/LBP/CD14 complex interacts with TLR4. LPS responses mediated through TLR4 require the presence of MD2, a cell surface protein. All these components form the complex of LPS/LBP/CD14/MD2/TLR4.19 Upon the interaction of LPS with TLR4 and associated receptor components, TLR4 exploits the combination of Mal/TIRAP and MyD88 at the plasma membrane to induce inflammatory gene expression (called MyD88-dependent pathway). In parallel, TLR4 is internalized to endosome by the interaction with TRAM, followed by a subsequent interaction with TRIF, leading to the transcription factor activation of interferon-regulatory factors which is responsible for type-I interferon (Interferon-α/β) production (termed MyD88-independent or TRIF-dependent pathway).20,21,22 MyD88-dependent pathways are generally involved in regulating inflammatory responses and innate immunity and subsequent adaptive immunity, while MyD88-independent pathways are assigned to anti-viral activity due to the involvement of Interferon-α/β production. Given that TLR4 activation induces the signaling pathways involved in inflammatory responses, innate and adaptive immunity, and anti-viral activity, engagement of TLR4 with LPS broadly impacts a wide range of human diseases including inflammatory diseases to infectious diseases.
The activation of TLRs induces the innate immunity which is an earlier evolutionary form of host defense and serves the secondary immune system by stimulating and orienting the adaptive immune responses. Indeed, mammalian TLR activation leads to expression and release of a plethora of cytokines, such as interleukins. These cytokines play direct or indirect role in adaptive immune system. It is clear that disruptions in innate immunity predispose human to microbial infections as described in the following examples. In the severely burned patient, the disruption of skin as not merely a barrier, but an organ adorned with antimicrobial peptides and first-line effecter cells like macrophages, poses great risks to microbial infections. In patients with cystic fibrosis, the alterations in salinity of the bronchial airway fluid appear to disable the function of antimicrobial peptides that are found in the respiratory epithelium, thereby leading to colonization and infection with organisms like Staphyloccoci and Pseudomonas.23,24
In the Drosophila , TOLL (Drosophila ortholog of mammalian TLR) participates in dorsal-ventral development. But in adult flies, TOLL induces the antifungal peptide, drosomycin, which is mediated through the activation of a transcription factor Dorsal.25 In comparison with TOLL, 18-wheeler causes the expression of the anti-bacterial peptide, attacin, through the activation of Dorsal-related immunity factor (DIF). While Dorsal and DIF are Drosophila NFκB proteins, Dorsal is selectively activated by TOLL and DIF is specifically activated by18-wheeler.25,26
Hundreds of anti-bacterial peptides have been reported to participate in innate immunity, not only of insects, but also of all multi-cellular organisms including human and plants. Among a wide variety of anti-microbial peptide, defensins are the representative with a wide spectra of anti-bacterial activity directed against various bacteria, fungi, and enveloped viruses.27 Although the molecular mechanisms are not fully understood, they may involve the transient appearance of channel-like structures. Defensins and most other anti-microbial peptides act by permeabilizing the cell membranes of microorganisms, resulting in the efflux of solutes. Defensins are major constituents of the microbicidal granules of blood granulocytes and are also abundantly expressed in intestinal epithelial cells specialized for host defense functions. A constitutively expressed human epithelial α-defensin is abundant in the kidney and the urogenital tract, and an infection- or cytokine-inducible β-defensin is abundant in the skin. In addition to defensins, mammals produce cathelicidins which are a group of myeloid antimicrobial peptides.28
In addition, the complement cascade plays one of the major roles in mammalian innate immunity. It is activated either directly or indirectly by microorganisms and leads to the phagocytosis through opsonization or the assembly of a pore-forming membrane attack complex on the surface of microorganism.29
LPS is the major constituent of the outer membrane of Gram-negative bacteria and specifically stimulates TLR4, resulting in the production of pleiotropic cytokines/chemokines. Given that the human colon harbors a large collection of commensal bacteria, the colonic lumen functions as a reservoir of LPS released from Gram-negative bacteria therein. Indeed, approximately 50 µg/mL of LPS could be observed in the human colon.30,31
The composition of intestinal microbes varies among individuals, depending on individual life conditions such as life stages, regimen, environment, genetic factors, and etc. Nevertheless, a well-orchestrated balance between Gram-negative and Gram-positive bacteria is maintained in the healthy human gut with a predominance of Gram-positive bacteria.32 Gram-negative bacteria, however, are suggested to be considerably increased in IBD patients33,34,35 and accumulated at high concentrations in an inflamed lesion of the intestine.36 Increased Gram-negative bacteria in the gut are able to increase the luminal amount of LPS, which consequently makes a strong effect on the development and perpetuation of intestinal inflammation. In line with this, our recent study demonstrated that increased LPS level in the colon resulted in the intestinal inflammation.37 Furthermore, it is worth noting that the expression of TLR4 was suggested to be increased in IBD patients.38 As a confirmatory study of this observation, the treatment of TLR4 antagonist was able to ameliorate mouse experimental colitis.39 Meanwhile, LPS was also suggested to work as a critical pathogenic factor inducing necrotizing enterocolitis.30 Together, these studies suggested that TLR4 activation by LPS should be an important pathogenic element related to the development and perpetuation of intestinal inflammatory diseases.
On the other hand, LPS was suggested to play a protective effect in a mouse epithelial injury model.40 Furthermore, LPS normally present in the gut is believed to be harmless, because the normal intestinal epithelium constantly exposed with gut microbiota might be tolerant to LPS.41,42 Although beneficial effects of gut LPS were suggested using animal experimental models, a growing body of evidence indicates that LPS in the intestine has a potency to promote the intestinal inflammation.

Financial support: None.

Conflict of interest: None.

  • 1. Raetz CR. Biochemistry of endotoxins. Annu Rev Biochem 1990;59:129–170.PMID: 1695830.ArticlePubMed
  • 2. Raetz CR, Ulevitch RJ, Wright SD, Sibley CH, Ding A, Nathan CF. Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J 1991;5:2652–2660.PMID: 1916089.ArticlePubMed
  • 3. Rietschel ET, Brade H. Bacterial endotoxins. Sci Am 1992;267:54–61.PMID: 1641625.ArticlePubMed
  • 4. Murakami A, Ohigashi H. Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals. Int J Cancer 2007;121:2357–2363.PMID: 17893865.ArticlePubMed
  • 5. Murray PJ, Smale ST. Restraint of inflammatory signaling by interdependent strata of negative regulatory pathways. Nat Immunol 2012;13:916–924.PMID: 22990889.ArticlePubMedPMCPDF
  • 6. Rhee SH, Hwang D. Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase. J Biol Chem 2000;275:34035–34040.PMID: 10952994.ArticlePubMed
  • 7. Bosshart H, Heinzelmann M. Targeting bacterial endotoxin: two sides of a coin. Ann N Y Acad Sci 2007;1096:1–17.PMID: 17405910.ArticlePubMed
  • 8. Ziegler-Heitbrock HW, Ulevitch RJ. CD14: cell surface receptor and differentiation marker. Immunol Today 1993;14:121–125.PMID: 7682078.ArticlePubMed
  • 9. Sultzer BM. Genetic control of leucocyte responses to endotoxin. Nature 1968;219:1253–1254.PMID: 4877918.ArticlePubMedPDF
  • 10. Glode LM, Jacques A, Mergenhagen SE, Rosenstreich DL. Resistance of macrophages from C3H/HeJ mice to the in vitro cytotoxic effects of endotoxin. J Immunol 1977;119:162–166.PMID: 326955.ArticlePubMedPDF
  • 11. Watson J, Riblet R. Genetic control of responses to bacterial lipopolysaccharides in mice. II. A gene that influences a membrane component involved in the activation of bone marrow-derived lymphocytes by lipipolysaccharides. J Immunol 1975;114:1462–1468.PMID: 123543.PubMed
  • 12. Ryan JL, McAdam KP. Genetic non-responsiveness of murine fibroblasts to bacterial endotoxin. Nature 1977;269:153–155.PMID: 333293.ArticlePubMedPDF
  • 13. Watson J, Kelly K, Largen M, Taylor BA. The genetic mapping of a defective LPS response gene in C3H/HeJ mice. J Immunol 1978;120:422–424.PMID: 202651.ArticlePubMedPDF
  • 14. Coutinho A, Meo T. Genetic basis for unresponsiveness to lipopolysaccharide in C57BL/10Cr mice. Immunogenetics 1978;7:17–24.PMID: 21302052.ArticlePubMed
  • 15. Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998;282:2085–2088.PMID: 9851930.ArticlePubMed
  • 16. Qureshi ST, Lariviere L, Leveque G, et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 1999;189:615–625.PMID: 9989976.ArticlePubMedPMC
  • 17. Choi YJ, Im E, Chung HK, Pothoulakis C, Rhee SH. TRIF mediates Toll-like receptor 5-induced signaling in intestinal epithelial cells. J Biol Chem 2010;285:37570–37578.PMID: 20855887.ArticlePubMedPMC
  • 18. Zanoni I, Granucci F. Role of CD14 in host protection against infections and in metabolism regulation. Front Cell Infect Microbiol 2013;3:32PMID: 23898465.ArticlePubMedPMC
  • 19. Akashi-Takamura S, Miyake K. TLR accessory molecules. Curr Opin Immunol 2008;20:420–425.PMID: 18625310.ArticlePubMed
  • 20. Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol 2008;9:361–368.PMID: 18297073.ArticlePubMedPMCPDF
  • 21. Kenny EF, O'Neill LA. Signalling adaptors used by Toll-like receptors: an update. Cytokine 2008;43:342–349.PMID: 18706831.ArticlePubMed
  • 22. Choi YJ, Jung J, Chung HK, Im E, Rhee SH. PTEN regulates TLR5-induced intestinal inflammation by controlling Mal/TIRAP recruitment. FASEB J 2013;27:243–254.PMID: 23038756.ArticlePubMedPMC
  • 23. Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, Wilson JM. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 1997;88:553–560.PMID: 9038346.ArticlePubMed
  • 24. Smith JJ, Travis SM, Greenberg EP, Welsh MJ. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 1996;85:229–236.PMID: 8612275.ArticlePubMed
  • 25. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996;86:973–983.PMID: 8808632.ArticlePubMed
  • 26. Williams MJ, Rodriguez A, Kimbrell DA, Eldon ED. The 18-wheeler mutation reveals complex antibacterial gene regulation in Drosophila host defense. EMBO J 1997;16:6120–6130.PMID: 9321392.ArticlePubMedPMC
  • 27. Zhao L, Lu W. Defensins in innate immunity. Curr Opin Hematol 2014;21:37–42.PMID: 24275690.ArticlePubMed
  • 28. Kahlenberg JM, Kaplan MJ. Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease. J Immunol 2013;191:4895–4901.PMID: 24185823.ArticlePubMed
  • 29. Minton K. Innate immunity: the inside story on complement activation. Nat Rev Immunol 2014;14:61PMID: 24378841.ArticlePubMedPDF
  • 30. Leaphart CL, Cavallo J, Gribar SC, et al. A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J Immunol 2007;179:4808–4820.PMID: 17878380.ArticlePubMed
  • 31. Sodhi CP, Shi XH, Richardson WM, et al. Toll-like receptor-4 inhibits enterocyte proliferation via impaired beta-catenin signaling in necrotizing enterocolitis. Gastroenterology 2010;138:185–196.PMID: 19786028.ArticlePubMed
  • 32. De Palma G, Nadal I, Medina M, et al. Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children. BMC Microbiol 2010;10:63PMID: 20181275.ArticlePubMedPMC
  • 33. Martin HM, Campbell BJ, Hart CA, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004;127:80–93.PMID: 15236175.ArticlePubMed
  • 34. Seksik P, Rigottier-Gois L, Gramet G, et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003;52:237–242.PMID: 12524406.ArticlePubMedPMC
  • 35. Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 2005;43:3380–3389.PMID: 16000463.ArticlePubMedPMC
  • 36. Heimesaat MM, Bereswill S, Fischer A, et al. Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii. J Immunol 2006;177:8785–8795.PMID: 17142781.ArticlePubMed
  • 37. Im E, Riegler FM, Pothoulakis C, Rhee SH. Elevated lipopolysaccharide in the colon evokes intestinal inflammation, aggravated in immune modulator-impaired mice. Am J Physiol Gastrointest Liver Physiol 2012;303:G490–G497.PMID: 22723263.ArticlePubMedPMC
  • 38. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000;68:7010–7017.PMID: 11083826.ArticlePubMedPMC
  • 39. Fort MM, Mozaffarian A, Stover AG, et al. A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease. J Immunol 2005;174:6416–6423.PMID: 15879143.ArticlePubMed
  • 40. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by tolllike receptors is required for intestinal homeostasis. Cell 2004;118:229–241.PMID: 15260992.ArticlePubMed
  • 41. Abreu MT, Arnold ET, Thomas LS, et al. TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J Biol Chem 2002;277:20431–20437.PMID: 11923281.ArticlePubMed
  • 42. Otte JM, Cario E, Podolsky DK. Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 2004;126:1054–1070.PMID: 15057745.ArticlePubMed
Fig. 1
The Gram-negative bacterial envelope is composed of two bacterial membranes, outer and inner membrane. The outer membrane is enriched with lipopolysaccharide (LPS), which is an identifying feature of Gram-negative bacteria such as Escherichia coli. The lipid portion of the outer layer of the outer membrane is exclusively composed of LPS molecules. A single E. coli cell possesses approximately 2 million LPS molecules.
ir-12-90-g001.jpg
Fig. 2
Chemical structure of the lipopolysaccharide (LPS) is presented. LPS consists of a polysaccharide, or long chain of sugar, and lipid A. The polysaccharide varies depending on bacterial species and is composed of O-specific chain (O-antigen) and two-part cores (Outer core and Inner core). Lipid A virtually includes two glucosamine sugars modified by phosphate and a variable number of fatty acids. It also has negatively charged phosphate groups.
ir-12-90-g002.jpg
Fig. 3
Different molecular species of lipid A are observed in various pathogenic Gram-negative bacteria.
ir-12-90-g003.jpg

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • Dietary condensed tannin supplementation improves growth performance and feed utilization of juvenile Largemouth bass (Micropterus salmoides) through positively regulating serum lipids and intestinal health
      Manqi Yang, Dahai Jiang, Liangliang Zhang, Liming Lu, Yong Xu, Mohd Shahnawaz Khan, Jianchun Jiang
      Aquaculture.2025; 595: 741607.     CrossRef
    • Gut Microbiota Mediates Neuroinflammation in Alzheimer’s Disease: Unraveling Key Factors and Mechanistic Insights
      Liang Junyi, Wang Yueyang, Liu Bin, Dong Xiaohong, Cai Wenhui, Zhang Ning, Zhang Hong
      Molecular Neurobiology.2025; 62(3): 3746.     CrossRef
    • Dynamic effects of Aeromonas sobria infection on intestinal morphology, microbiota and goblet cells of rainbow trout (Oncorhynchus mykiss)
      Li-Ping Liu, Peng-Tian Kang, Feng-Yuan Ding, Dong-Hong Shao, Bao-Shan Wang, Juan Yang, Wen-Hui Gao, Wang-Dong Zhang, Wen-Hui Wang, Ji-Xing Liu
      Aquaculture.2025; 600: 742238.     CrossRef
    • Effect of molecular weight of tyramine-modified hyaluronan on polarization state of THP-1 and peripheral blood mononuclear cells-derived macrophages
      Jacek K. Wychowaniec, Ezgi Irem Bektas, Andrea J. Vernengo, Marcia Muerner, Marielle Airoldi, Paul Sean Tipay, Jiranuwat Sapudom, Jeremy Teo, David Eglin, Matteo D'Este
      Biomaterials Advances.2025; 169: 214166.     CrossRef
    • GLP-1 and IL-6 regulates obesity in the gut and brain
      Kun Yang, Yu-ting Wu, Yan He, Jin-xiu Dai, Yu-lu Luo, Jing-hui Xie, Wei-jun Ding
      Life Sciences.2025; 362: 123339.     CrossRef
    • Efecto del consumo de polifenoles sobre biomarcadores de inflamación y endotoxemia en personas con obesidad: una revisión sistemática.
      Luz Adriana López González, Clara Helena González Correa, Elcy Yaned Astudillo Muñoz, Manuel Felipe Jaramillo López
      Nutrición Clínica y Dietética Hospitalaria.2025;[Epub]     CrossRef
    • Neuromodulatory effect of troxerutin against doxorubicin and cyclophosphamide-induced cognitive impairment in rats: Potential crosstalk between gut–brain and NLRP3 inflammasome axes
      Nada K. Gamal, Reem N. El-Naga, Iriny M. Ayoub, Mina Y. George
      International Immunopharmacology.2025; 149: 114216.     CrossRef
    • Inflammation o'clock: interactions of circadian rhythms with inflammation‐induced skeletal muscle atrophy
      Francielly Morena da Silva, Karyn A. Esser, Kevin A. Murach, Nicholas P. Greene
      The Journal of Physiology.2024; 602(23): 6587.     CrossRef
    • Preclinical evidence using synthetic compounds and natural products indicates that AMPK represents a potential pharmacological target for the therapy of pulmonary diseases
      Chao Yang, Limor Rubin, Xiyong Yu, Philip Lazarovici, Wenhua Zheng
      Medicinal Research Reviews.2024; 44(3): 1326.     CrossRef
    • Deciphering the intricate linkage between the gut microbiota and Alzheimer's disease: Elucidating mechanistic pathways promising therapeutic strategies
      Junyi Liang, Yueyang Wang, Bin Liu, Xiaohong Dong, Wenhui Cai, Ning Zhang, Hong Zhang
      CNS Neuroscience & Therapeutics.2024;[Epub]     CrossRef
    • Isoorientin inhibits NLRP3 inflammasome activation by activating Nrf2 signaling to delay the progression of osteoarthritis
      Yuxin Deng, Xiaoying Zhao, Yu Chen, Chenchao Li, Qingyu Deng, Chenyu Wu, Zongxin Zhu, Xiaolei Zhang, Yifei Zhou, Jingquan Yang
      Journal of Functional Foods.2024; 116: 106187.     CrossRef
    • One‐Pot Synthesis of Nanoflower‐Like Zn2SnS4 as Nanozymes for Highly Sensitive Electrochemical Detection of H2O2 Released by Living Cells
      Xia Wen, Jiancong Ni, Shunmu Zeng, Zhiping Song, Weiwei Qiu
      Chemistry – A European Journal.2024;[Epub]     CrossRef
    • Lipopolysaccharide with long O-antigen is crucial for Salmonella Enteritidis to evade complement activity and to facilitate bacterial survival in vivo in the Galleria mellonella infection model
      Eva Krzyżewska-Dudek, Vinaya Dulipati, Katarzyna Kapczyńska, Mateusz Noszka, Carmen Chen, Juha Kotimaa, Marta Książczyk, Bartłomiej Dudek, Gabriela Bugla-Płoskońska, Krzysztof Pawlik, Seppo Meri, Jacek Rybka
      Medical Microbiology and Immunology.2024;[Epub]     CrossRef
    • Mogroside Alleviates Diabetes Mellitus and Modulates Intestinal Microflora in Type 2 Diabetic Mice
      Tiantian Qin, Yuqing Li, Yijing Wu, Fanyan Meng, Guobiao Lin, Xing Xia
      Biological and Pharmaceutical Bulletin.2024; 47(5): 1043.     CrossRef
    • Chronic PM2.5 exposure disrupts intestinal barrier integrity via microbial dysbiosis-triggered TLR2/5-MyD88-NLRP3 inflammasome activation
      Zihan Ran, Jingcheng Yang, Liang Liu, Shaobo Wu, YanPeng An, Wanwan Hou, Tianyuan Cheng, Youyi Zhang, Yiqing Zhang, Yechao Huang, Qianyue Zhang, Jiaping Wan, Xuemei Li, Baoling Xing, Yuchen Ye, Penghao Xu, Zhenghu Chen, Jinzhuo Zhao, Rui Li
      Environmental Research.2024; 258: 119415.     CrossRef
    • Silencing miR-155–5p expression improves intestinal damage through inhibiting inflammation and ferroptosis in necrotizing enterocolitis
      Le Zhang, Weilai Jin, Mengyuan Hu, Yinglin Su, Yiting Zhang, Fuqiang Yuan, Yuanyuan Fang, Zhengying Li, Yawen Li, Chaozhi Bu, Wenhao Zhou
      Heliyon.2024; 10(17): e37087.     CrossRef
    • Monoclonal antibodies: From magic bullet to precision weapon
      Hassan Aboul-Ella, Asmaa Gohar, Aya Ahmed Ali, Lina M. Ismail, Adham Ezz El-Regal Mahmoud, Walid F. Elkhatib, Heba Aboul-Ella
      Molecular Biomedicine.2024;[Epub]     CrossRef
    • The Gut Microbiota Modulates Neuroinflammation in Alzheimer's Disease: Elucidating Crucial Factors and Mechanistic Underpinnings
      Jianshe Yang, Junyi Liang, Niyuan Hu, Ningjuan He, Bin Liu, Guoliang Liu, Ying Qin
      CNS Neuroscience & Therapeutics.2024;[Epub]     CrossRef
    • Utilizing Flaxseed as an Antimicrobial Alternative in Chickens: Integrative Review for Salmonella enterica and Eimeria
      William C. Weston, Karen H. Hales, Dale B. Hales
      Current Issues in Molecular Biology.2024; 46(11): 12322.     CrossRef
    • Influence of intestinal dysbiosis on the course of authistic spectrum: literature review
      E. O. Grigoryants, Yu. V. Chervinets, V. M. Chervinets, E. S. Rumyantseva
      Astrakhan medical journal.2024; 19(4): 16.     CrossRef
    • Prebiotic properties of the polysaccharide from Rosa roxburghii Tratt fruit and its protective effects in high-fat diet-induced intestinal barrier dysfunction: A fecal microbiota transplantation study
      Lei Wang, Pan Zhang, Jie Chen, Chao Li, Yingpeng Tian, Fei Xu
      Food Research International.2023; 164: 112400.     CrossRef
    • Dietary fat induced chylomicron-mediated LPS translocation in a bicameral Caco-2cell model
      Monic M. M. Tomassen, Coen Govers, A. Paul Vos, Nicole J. W. de Wit
      Lipids in Health and Disease.2023;[Epub]     CrossRef
    • Endotoxemia and Gastrointestinal Cancers: Insight into the Mechanisms Underlying a Dangerous Relationship
      Vittoria Manilla, Natalia Di Tommaso, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani
      Microorganisms.2023; 11(2): 267.     CrossRef
    • The regulatory effects of second-generation antipsychotics on lipid metabolism: Potential mechanisms mediated by the gut microbiota and therapeutic implications
      Hui Chen, Ting Cao, Bikui Zhang, Hualin Cai
      Frontiers in Pharmacology.2023;[Epub]     CrossRef
    • Disturbance of intestinal permeability and its role in the development of cardiovascular complications in persons with inflammatory bowel diseases
      O. V. Khlynova, E. A. Stepina
      Experimental and Clinical Gastroenterology.2023; (11): 36.     CrossRef
    • Dietary supplementation of β-1, 3-glucan improves the intestinal health of white shrimp (Litopenaeus vannamei) by modulating intestinal microbiota and inhibiting inflammatory response
      Kaikai Shen, Lixin Bao, Muxin Liu, Wen Lei, Qin Zhou, Jiali Ding, Peng Fang, Baoqing Hu, Chungen Wen, Vikas Kumar, Mo Peng, Gang Yang
      Frontiers in Immunology.2023;[Epub]     CrossRef
    • Multi-Species Probiotic Strain Mixture Enhances Intestinal Barrier Function by Regulating Inflammation and Tight Junctions in Lipopolysaccharides Stimulated Caco-2 Cells
      Hyeontak Han, Yeji You, Soyoung Cha, Tae-Rahk Kim, Minn Sohn, Jeseong Park
      Microorganisms.2023; 11(3): 656.     CrossRef
    • Haslea ostrearia Pigment Marennine Affects Key Actors of Neuroinflammation and Decreases Cell Migration in Murine Neuroglial Cell Model
      Sarah Méresse, Hélène Gateau, Tessa Tirnan, Vanessa Larrigaldie, Nathalie Casse, Pamela Pasetto, Jean-Luc Mouget, Stéphane Mortaud, Mostefa Fodil
      International Journal of Molecular Sciences.2023; 24(6): 5388.     CrossRef
    • Optimal low-intensity pulsed ultrasound stimulation for promoting anti-inflammatory effects in macrophages
      Francesco Iacoponi, Andrea Cafarelli, Francesco Fontana, Tiziano Pratellesi, Erik Dumont, Ivana Barravecchia, Debora Angeloni, Leonardo Ricotti
      APL Bioengineering.2023;[Epub]     CrossRef
    • Dendrobium officinalis Six Nostrum Promotes Intestinal Urate Underexcretion via Regulations of Urate Transporter Proteins in Hyperuricemic Rats
      Hongzhang Ge, Zetian Jiang, Bo Li, Peiyao Xu, Hansong Wu, Xinglishang He, Wanfeng Xu, Zhi Huang, Taoxiu Xiong, Ping Wang, Guiyuan Lv, Suhong Chen
      Combinatorial Chemistry & High Throughput Screening.2023; 26(4): 848.     CrossRef
    • The effect of neuroinflammation on the cerebral metabolism at baseline and after neural stimulation in neurodegenerative diseases
      Fatima Cheataini, Nissrine Ballout, Tareq Al Sagheer
      Journal of Neuroscience Research.2023; 101(8): 1360.     CrossRef
    • Co-Stimulation of AGEs and LPS Induces Inflammatory Mediators through PLCγ1/JNK/NF-κB Pathway in MC3T3-E1 Cells
      Natsuko Tanabe, Keiko Tomita, Soichiro Manaka, Risa Ichikawa, Tadahiro Takayama, Takayuki Kawato, Misae Ono, Yuma Masai, Akihisa Utsu, Naoto Suzuki, Shuichi Sato
      Cells.2023; 12(10): 1383.     CrossRef
    • Salivary endotoxin detection using combined mono/polyclonal antibody-based sandwich-type lateral flow immunoassay device
      Daewoo Han, Sancai Xie, Andrew J. Steckl
      Sensors & Diagnostics.2023; 2(6): 1460.     CrossRef
    • An Update on the Therapeutic Potential of Antimicrobial Peptides against Acinetobacter baumannii Infections
      Karyne Rangel, Guilherme Curty Lechuga, David W. Provance, Carlos M. Morel, Salvatore G. De Simone
      Pharmaceuticals.2023; 16(9): 1281.     CrossRef
    • Gut–Brain Crosstalk and the Central Mechanisms of Orofacial Pain
      Ran Tao, Sufang Liu, Joshua Crawford, Feng Tao
      Brain Sciences.2023; 13(10): 1456.     CrossRef
    • Bacterial lipopolysaccharide inhibits colonic carrier-mediated uptake of thiamin pyrophosphate: roles for TLR4 receptor and NF-κB/P38/JNK signaling pathway
      Selvaraj Anthonymuthu, Subrata Sabui, Katherine Lee, Alaullah Sheikh, James M. Fleckenstein, Hamid M. Said
      American Journal of Physiology-Cell Physiology.2023; 325(3): C758.     CrossRef
    • Review of Phytochemical Potency as a Natural Anti-Helicobacter pylori and Neuroprotective Agent
      Yohanes Tandoro, Bo-Kai Chen, Asif Ali, Chin-Kun Wang
      Molecules.2023; 28(20): 7150.     CrossRef
    • Hyperimmune bovine colostrum containing lipopolysaccharide antibodies (IMM124-E) has a nondetrimental effect on gut microbial communities in unchallenged mice
      Rachele Gore, Mitra Mohsenipour, Jennifer L. Wood, Gayathri K. Balasuriya, Elisa L. Hill-Yardin, Ashley E. Franks, Manuela Raffatellu
      Infection and Immunity.2023;[Epub]     CrossRef
    • Decoding the role of gut microbiota in Alzheimer’s pathogenesis and envisioning future therapeutic avenues
      Junyi Liang, Bin Liu, Xiaohong Dong, Yueyang Wang, Wenhui Cai, Ning Zhang, Hong Zhang
      Frontiers in Neuroscience.2023;[Epub]     CrossRef
    • Of Soldiers and Their Ghosts: Are We Ready for a Review of PTSD Evidence?
      Adonis Sfera, Jonathan J. Anton, Hassan Imran, Zisis Kozlakidis, Carolina Klein, Carolina Osorio
      BioMed.2023; 3(4): 484.     CrossRef
    • Association of Endotoxemia with Low-Grade Inflammation, Metabolic Syndrome and Distinct Response to Lipopolysaccharide in Type 1 Diabetes
      Aleksejs Fedulovs, Leonora Pahirko, Kaspars Jekabsons, Liga Kunrade, Jānis Valeinis, Una Riekstina, Valdis Pīrāgs, Jelizaveta Sokolovska
      Biomedicines.2023; 11(12): 3269.     CrossRef
    • Intestinal Barrier Function and Immune Homeostasis Are Missing Links in Obesity and Type 2 Diabetes Development
      Sylvia Riedel, Carmen Pheiffer, Rabia Johnson, Johan Louw, Christo J. F. Muller
      Frontiers in Endocrinology.2022;[Epub]     CrossRef
    • PPAR‐γ agonist pioglitazone alleviates inflammatory response induced by lipopolysaccharides in osteoblast cells
      Hua‐jun Yu, Lai‐jie Wang, Kai Huang, Qiao‐feng Guo, Bing‐yuan Lin, Yi‐yang Liu, Ming Yu, Gou‐ping Ma
      Journal of Orthopaedic Research.2022; 40(11): 2471.     CrossRef
    • Metformin attenuated sepsis-related liver injury by modulating gut microbiota
      Huoyan Liang, Heng Song, Xiaojuan Zhang, Gaofei Song, Yuze Wang, Xianfei Ding, Xiaoguang Duan, Lifeng Li, Tongwen Sun, Quancheng Kan
      Emerging Microbes & Infections.2022; 11(1): 815.     CrossRef
    • Periodontitis and cardiometabolic disorders: The role of lipopolysaccharide and endotoxemia
      Pirkko J. Pussinen, Elisa Kopra, Milla Pietiäinen, Markku Lehto, Svetislav Zaric, Susanna Paju, Aino Salminen
      Periodontology 2000.2022; 89(1): 19.     CrossRef
    • Response of periodontal ligament stem cells to lipopolysaccharide and calcium silicate-based materials
      Marlus da Silva Pedrosa, Handially dos Santos Vilela, Juliana Garuba Rahhal, Natália Pieretti Bueno, Fabianne Soares Lima, Fernando Neves Nogueira, Carla Renata Sipert
      Brazilian Dental Journal.2022; 33(2): 73.     CrossRef
    • Metformin Mitigates Sepsis-Related Neuroinflammation via Modulating Gut Microbiota and Metabolites
      Huayan Zhao, Yuanjun Lyu, Ruiqing Zhai, Guiying Sun, Xianfei Ding
      Frontiers in Immunology.2022;[Epub]     CrossRef
    • Anti-Inflammatory Effects of Mitrephora sirikitiae Leaf Extract and Isolated Lignans in RAW 264.7 Cells
      Supachoke Mangmool, Chayaporn Limpichai, Khine Kyi Han, Vichai Reutrakul, Natthinee Anantachoke
      Molecules.2022; 27(10): 3313.     CrossRef
    • The Effect of N-Acetylation on the Anti-Inflammatory Activity of Chitooligosaccharides and Its Potential for Relieving Endotoxemia
      Wentong Hao, Kecheng Li, Xiangyun Ge, Haoyue Yang, Chaojie Xu, Song Liu, Huahua Yu, Pengcheng Li, Ronge Xing
      International Journal of Molecular Sciences.2022; 23(15): 8205.     CrossRef
    • Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework
      Laure-Alix Clerbaux, Maria Cristina Albertini, Núria Amigó, Anna Beronius, Gillina F. G. Bezemer, Sandra Coecke, Evangelos P. Daskalopoulos, Giusy del Giudice, Dario Greco, Lucia Grenga, Alberto Mantovani, Amalia Muñoz, Elma Omeragic, Nikolaos Parissis, M
      Journal of Clinical Medicine.2022; 11(15): 4464.     CrossRef
    • Monoclonal Antibodies for Bacterial Pathogens: Mechanisms of Action and Engineering Approaches for Enhanced Effector Functions
      Fabiola Vacca, Claudia Sala, Rino Rappuoli
      Biomedicines.2022; 10(9): 2126.     CrossRef
    • Single-cell RNA analysis of chemokine expression in heterogeneous CD14+ monocytes with lipopolysaccharide-induced bone resorption
      Junpan Luo, Jiarui Lu, Jie Zeng, Yuanyuan Ma, Qimei Gong, Zhuyu Wang, Xiaolei Zhang, Jingjing Quan
      Experimental Cell Research.2022; 420(2): 113343.     CrossRef
    • Hydrogen Sulfide (H2S) Signaling as a Protective Mechanism against Endogenous and Exogenous Neurotoxicants
      Michael Aschner, Anatoly V. Skalny, Tao Ke, Joao BT da Rocha, Monica MB Paoliello, Abel Santamaria, Julia Bornhorst, Lu Rongzhu, Andrey A. Svistunov, Aleksandra B. Djordevic, Alexey A. Tinkov
      Current Neuropharmacology.2022; 20(10): 1908.     CrossRef
    • Gut as an Alternative Entry Route for SARS-CoV-2: Current Evidence and Uncertainties of Productive Enteric Infection in COVID-19
      Laure-Alix Clerbaux, Sally A. Mayasich, Amalia Muñoz, Helena Soares, Mauro Petrillo, Maria Cristina Albertini, Nicolas Lanthier, Lucia Grenga, Maria-Joao Amorim
      Journal of Clinical Medicine.2022; 11(19): 5691.     CrossRef
    • Probiotics Bacillus cereus and B. subtilis reshape the intestinal microbiota of Pengze crucian carp (Carassius auratus var. Pengze) fed with high plant protein diets
      Jiamin Li, Peng Fang, Xinwen Yi, Vikas Kumar, Mo Peng
      Frontiers in Nutrition.2022;[Epub]     CrossRef
    • Biological functions of sialic acid as a component of bacterial endotoxin
      Bartłomiej Dudek, Jacek Rybka, Gabriela Bugla-Płoskońska, Agnieszka Korzeniowska-Kowal, Bożena Futoma-Kołoch, Aleksandra Pawlak, Andrzej Gamian
      Frontiers in Microbiology.2022;[Epub]     CrossRef
    • Interactions between gut microbiota and Parkinson's disease: The role of microbiota-derived amino acid metabolism
      Wang Wang, Shujun Jiang, Chengcheng Xu, Lili Tang, Yan Liang, Yang Zhao, Guoxue Zhu
      Frontiers in Aging Neuroscience.2022;[Epub]     CrossRef
    • Casein Oligochitosan-Glycation by Transglutaminase Enhances the Anti-Inflammatory Potential of Casein Hydrolysates to the Lipopolysaccharide-Stimulated IEC-6 Cells
      Na Chen, Li Wang, Qiang Zhang, Xin-Huai Zhao, Jia Shi
      Nutrients.2022; 14(3): 686.     CrossRef
    • Casein Lactose-Glycation of the Maillard-Type Attenuates the Anti-Inflammatory Potential of Casein Hydrolysate to IEC-6 Cells with Lipopolysaccharide Stimulation
      Na Chen, Yu Fu, Zhen-Xing Wang, Xin-Huai Zhao
      Nutrients.2022; 14(23): 5067.     CrossRef
    • Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions
      Shireen Mohammad, Christoph Thiemermann
      Frontiers in Immunology.2021;[Epub]     CrossRef
    • Serum 1,3-beta-D-glucan as a noninvasive test to predict histologic activity in patients with inflammatory bowel disease
      Katia Farias e Silva, Hayandra F Nanini, Cynthia Machado Cascabulho, Siane L B Rosas, Patricia T Santana, Antonio José de V Carneiro, Elias Anaissie, Marcio Nucci, Heitor Siffert Pereira de Souza
      World Journal of Gastroenterology.2021; 27(9): 866.     CrossRef
    • New Avenues for Parkinson’s Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota
      Marina Lorente-Picón, Ariadna Laguna
      Biomolecules.2021; 11(3): 433.     CrossRef
    • The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus
      Chae Bin Lee, Soon Uk Chae, Seong Jun Jo, Ui Min Jerng, Soo Kyung Bae
      International Journal of Molecular Sciences.2021; 22(7): 3566.     CrossRef
    • Effect of condensed tannins on growth performance, intestinal immune capacity and bacterial microbiomes of Lateolabrax japonicus
      Kai Peng, Hongxia Zhao, Guoxia Wang, Bing Chen, Wenyan Mo, Yanhua Huang
      Aquaculture Research.2021; 52(11): 5321.     CrossRef
    • Effect of Ulinastatin on Early Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Surgery: A Systemic Review and Meta-Analysis
      Mei Duan, Fangyan Liu, Huiqun Fu, Shuai Feng, Xue Wang, Tianlong Wang
      Frontiers in Neuroscience.2021;[Epub]     CrossRef
    • Pathological and Therapeutic Approach to Endotoxin-Secreting Bacteria Involved in Periodontal Disease
      Rosalia Marcano, M. Ángeles Rojo, Damián Cordoba-Diaz, Manuel Garrosa
      Toxins.2021; 13(8): 533.     CrossRef
    • Research Progress of Ulinastatin in Preventing and Treating Postoperative Cognitive Dysfunction
      学英 陈
      Advances in Clinical Medicine.2021; 11(08): 3758.     CrossRef
    • The Potential for Phospholipids in the Treatment of Airway Inflammation: An Unexplored Solution
      Varsha Komalla, Meenu Mehta, Fatima Achi, Kamal Dua, Mehra Haghi
      Current Molecular Pharmacology.2021; 14(3): 333.     CrossRef
    • Fundamental and applied aspects of catechins from different sources: a review
      Alessandra Cristina Pedro, Giselle Maria Maciel, Valéria Rampazzo Ribeiro, Charles Windson Isidoro Haminiuk
      International Journal of Food Science & Technology.2020; 55(2): 429.     CrossRef
    • Recent Advances in Lipopolysaccharide Recognition Systems
      Lalita Mazgaeen, Prajwal Gurung
      International Journal of Molecular Sciences.2020; 21(2): 379.     CrossRef
    • miR‐146b‐5p Plays a Critical Role in the Regulation of Autophagy in ∆per Brucella melitensis‐Infected RAW264.7 Cells
      Jiao Hanwei, Xin Nie, Huapei Zhu, Baobao Li, Feng Pang, Xiaohong Yang, Ruiyong Cao, Xiaojian Yang, Shu Zhu, Dongmei Peng, Yaying Li, Guohua Li, Zhenxing Zhang, Haifeng Huang, Kailian Xu, Tianjing Zhao, Ying Cheng, Chuangfu Chen, Li Du, Fengyang Wang, Juan
      BioMed Research International.2020;[Epub]     CrossRef
    • Cancer immunotherapy using a polysaccharide from Codium fragile in a murine model
      Hae-Bin Park, Seong-Min Lim, Juyoung Hwang, Wei Zhang, SangGuan You, Jun-O Jin
      OncoImmunology.2020;[Epub]     CrossRef
    • The influence of the gastrointestinal microbiome on infant colic
      Abdelhalim Ouald Chaib, Elvira Ingrid Levy, Mariam Ouald Chaib, Yvan Vandenplas
      Expert Review of Gastroenterology & Hepatology.2020; 14(10): 919.     CrossRef
    • MiR-141-3p ameliorates RIPK1-mediated necroptosis of intestinal epithelial cells in necrotizing enterocolitis
      Xiang Li, Ying Wang, Yijiang Wang, Xingbo He
      Aging.2020; 12(18): 18073.     CrossRef
    • Glucose transporter 4 mediates LPS-induced IL-6 production in osteoblasts under high glucose conditions
      Shunichiro Kato, Natsuko Tanabe, Mayu Nagao, Jumpei Sekino, Keiko Tomita, Mayu Sakai, Kimiko Abe, Naoto Suzuki, Koichiro Ueda
      Journal of Oral Science.2020; 62(4): 423.     CrossRef
    • Polyreactive Transformation of Class G Immunoglobulins as a Vector for Search of Potential Means for Improving the Activity of Anti-endotoxin Immunity
      A. I. Gordienko, N. V. Khimich, V. A. Beloglazov, A. V. Kubyshkin, M. Yu. Yakovlev
      Human Physiology.2020; 46(5): 554.     CrossRef
    • A P4 medicine perspective of gut microbiota and prediabetes: Systems analysis and personalized intervention
      Qiongrong Huang, Qiaojun Fang, Zhiyuan Hu
      Journal of Translational Internal Medicine.2020; 8(3): 119.     CrossRef
    • Role of the Microbiota in the Modulation of Vaccine Immune Responses
      Annalisa Ciabattini, Raffaela Olivieri, Elisa Lazzeri, Donata Medaglini
      Frontiers in Microbiology.2019;[Epub]     CrossRef
    • Microchip electrophoretic detection of bacterial lipopolysaccharide based on aptamer-modified magnetic beads and polymerase chain amplification
      Zhi Li, Feifei Luo, Ge Dai, Yuqi Lu, Shiyun Ai, Pingang He, Qingjiang Wang
      Microchemical Journal.2019; 150: 104178.     CrossRef
    • Comparison of inflammatory cytokine-inducing activity of lipopolysaccharides from major periodontal bacteria
      So-Hee Kim, In-Chol Kang
      International Journal of Oral Biology.2019; 44(4): 160.     CrossRef
    • Lipopolysaccharide induces tumor necrosis factor receptor-1 independent relocation of lymphocytes from the red pulp of the mouse spleen
      Ivana M. Lalić, Rudolf Bichele, Anja Repar, Sanja Z. Despotović, Saša Petričević, Martti Laan, Pärt Peterson, Jürgen Westermann, Živana Milićević, Ivana Mirkov, Novica M. Milićević
      Annals of Anatomy - Anatomischer Anzeiger.2018; 216: 125.     CrossRef
    • Evasion of Human Neutrophil-Mediated Host Defense duringToxoplasma gondiiInfection
      Tatiane S. Lima, Lanny Gov, Melissa B. Lodoen, Louis M. Weiss
      mBio.2018;[Epub]     CrossRef
    • Effects of short-term dietary restriction and glutamine supplementation in vitro on the modulation of inflammatory properties
      Dalila C. de Oliveira, Ed Wilson Santos, Amanda Nogueira-Pedro, José Guilherme Xavier, Primavera Borelli, Ricardo Ambrósio Fock
      Nutrition.2018; 48: 96.     CrossRef
    • Dysbiosis of gut microbiota and microbial metabolites in Parkinson’s Disease
      Meng-Fei Sun, Yan-Qin Shen
      Ageing Research Reviews.2018; 45: 53.     CrossRef
    • Ulinastatin May Significantly Improve Postoperative Cognitive Function of Elderly Patients Undergoing Spinal Surgery by Reducing the Translocation of Lipopolysaccharide and Systemic Inflammation
      Min Zhang, Yan-Hua Zhang, Hui-Qun Fu, Qing-Ming Zhang, Tian-Long Wang
      Frontiers in Pharmacology.2018;[Epub]     CrossRef
    • Antimicrobial Peptides: Mechanisms of Action and Resistance
      B. Bechinger, S.-U. Gorr
      Journal of Dental Research.2017; 96(3): 254.     CrossRef
    • Effects of cyanobacteria Oscillatoria sp. lipopolysaccharide on B cell activation and Toll-like receptor 4 signaling
      Michelle Swanson-Mungerson, Ryan Incrocci, Vijay Subramaniam, Philip Williams, Mary L. Hall, Alejandro M.S. Mayer
      Toxicology Letters.2017; 275: 101.     CrossRef
    • Low-intensity pulsed ultrasound inhibits lipopolysaccharide-induced IL-6 and RANKL expression in osteoblasts
      Mayu Nagao, Natsuko Tanabe, Soichiro Manaka, Tadahiro Takayama, Takayuki Kawato, Go Torigoe, Jumpei Sekino, Naoya Tsukune, Manami Ozaki, Masao Maeno, Naoto Suzuki, Shuichi Sato
      Journal of Oral Science.2017; 59(2): 303.     CrossRef
    • Conformational Dynamics of the Lipopolysaccharide from Escherichia coli O91 Revealed by Nuclear Magnetic Resonance Spectroscopy and Molecular Simulations
      Pilar Blasco, Dhilon S. Patel, Olof Engström, Wonpil Im, Göran Widmalm
      Biochemistry.2017; 56(29): 3826.     CrossRef
    • RANKL coordinates multiple osteoclastogenic pathways by regulating expression of ubiquitin ligase RNF146
      Yoshinori Matsumoto, Jose Larose, Oliver A. Kent, Melissa Lim, Adele Changoor, Lucia Zhang, Yaryna Storozhuk, Xiaohong Mao, Marc D. Grynpas, Feng Cong, Robert Rottapel
      Journal of Clinical Investigation.2017; 127(4): 1303.     CrossRef
    • Dietary patterns reflecting healthy food choices are associated with lower serum LPS activity
      Aila J Ahola, Mariann I. Lassenius, Carol Forsblom, Valma Harjutsalo, Markku Lehto, Per-Henrik Groop
      Scientific Reports.2017;[Epub]     CrossRef
    • MicroRNA mediated regulation of immunity against gram-negative bacteria
      Jonathon Keck, Rishein Gupta, Lane K. Christenson, Bernard P. Arulanandam
      International Reviews of Immunology.2017; 36(5): 287.     CrossRef
    • Mogroside IIIE Attenuates LPS‐Induced Acute Lung Injury in Mice Partly Through Regulation of the TLR4/MAPK/NF‐κB Axis via AMPK Activation
      Lijun Tao, Fengyan Cao, Gonghao Xu, Haifeng Xie, Mian Zhang, Chaofeng Zhang
      Phytotherapy Research.2017; 31(7): 1097.     CrossRef
    • Changes in serum levels of lipopolysaccharides and CD26 in patients with Crohn's disease
      Daniéla Oliveira Magro, Paulo Gustavo Kotze, Carlos Augusto Real Martinez, Michel Gardere Camargo, Dioze Guadagnini, Antonio Ramos Calixto, Ana Carolina Junqueira Vasques, Maria de Lourdes Setsuko Ayrizono, Bruno Geloneze, José Carlos Pareja, Mario José S
      Intestinal Research.2017; 15(3): 352.     CrossRef
    • LIPUS suppressed LPS‐induced IL‐1α through the inhibition of NF‐κB nuclear translocation via AT1‐PLCβ pathway in MC3T3‐E1 cells
      Mayu Nagao, Natsuko Tanabe, Soichiro Manaka, Masako Naito, Jumpei Sekino, Tadahiro Takayama, Takayuki Kawato, Go Torigoe, Shunichiro Kato, Naoya Tsukune, Masao Maeno, Naoto Suzuki, Shuichi Sato
      Journal of Cellular Physiology.2017; 232(12): 3337.     CrossRef
    • Autophagy can alleviate severe burn-induced damage to the intestinal tract in mice
      Duanyang Zhang, Wei Qiu, Peng Wang, Pan Zhang, Fang Zhang, PeiP. Wang, Yong Sun
      Surgery.2017; 162(2): 408.     CrossRef
    • Protective effect of wogonin on endotoxin‐induced acute lung injury via reduction of p38 MAPK and JNK phosphorylation
      Cheng‐Yu Wei, Hai‐Lun Sun, Ming‐Ling Yang, Ching‐Ping Yang, Li‐You Chen, Yi‐Ching Li, Chien‐Ying Lee, Yu‐Hsiang Kuan
      Environmental Toxicology.2017; 32(2): 397.     CrossRef
    • Lipopolysaccharide from Crypt-Specific Core Microbiota Modulates the Colonic Epithelial Proliferation-to-Differentiation Balance
      Tomoaki Naito, Céline Mulet, Cristina De Castro, Antonio Molinaro, Azadeh Saffarian, Giulia Nigro, Marion Bérard, Mélanie Clerc, Amy B. Pedersen, Philippe J. Sansonetti, Thierry Pédron, B. Brett Finlay, Andrew Gewirtz, Kevin Foster, Scott Hultgren
      mBio.2017;[Epub]     CrossRef
    • Effects of lipopolysaccharide on the histomorphology and expression of toll-like receptor 4 in the chicken trachea and lung
      Abdur Rahman Ansari, Xiao-Hong Ge, Hai-Bo Huang, Xi-Yao Huang, Xing Zhao, Ke-Mei Peng, Ju-Ming Zhong, Hua-Zhen Liu
      Avian Pathology.2016; 45(5): 530.     CrossRef
    • Can Proton Pump Inhibitors Increase Incidence of Nonsteroidal Anti-inflammatory Drug-induced Small Bowel Injury?
      Seong Ran Jeon
      The Korean Journal of Gastroenterology.2016; 68(2): 123.     CrossRef
    • Inflammatory stimuli promote growth and invasion of pancreatic cancer cells through NF-κB pathway dependent repression of PP2Ac
      Min Tao, Lu Liu, Meng Shen, Qiaoming Zhi, Fei-Ran Gong, Binhua P. Zhou, Yadi Wu, Haiyan Liu, Kai Chen, Bairong Shen, Meng-Yao Wu, Liu-Mei Shou, Wei Li
      Cell Cycle.2016; 15(3): 381.     CrossRef
    • Ligustrazine disrupts lipopolysaccharide-activated NLRP3 inflammasome pathway associated with inhibition of Toll-like receptor 4 in hepatocytes
      Feng Zhang, Huanhuan Jin, Li Wu, Jiangjuan Shao, Xiafei Wu, Yin Lu, Shizhong Zheng
      Biomedicine & Pharmacotherapy.2016; 78: 204.     CrossRef
    • Polyphenol extracts interfere with bacterial lipopolysaccharide in vitro and decrease postprandial endotoxemia in human volunteers
      Ximena Wong, Ana María Madrid, Karina Tralma, Romina Castillo, Catalina Carrasco-Pozo, Paola Navarrete, Caroll Beltrán, Edgar Pastene, Martin Gotteland
      Journal of Functional Foods.2016; 26: 406.     CrossRef
    • A20 inhibits lipopolysaccharide-induced inflammation in enterocytes
      Cui-Fang Zheng, Jie-Ru Shi, Ying Huang, Sheng-Nan Wang
      World Journal of Gastrointestinal Pharmacology and Therapeutics.2016; 7(4): 540.     CrossRef
    • Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease
      Francesca Pistollato, Sandra Sumalla Cano, Iñaki Elio, Manuel Masias Vergara, Francesca Giampieri, Maurizio Battino
      Nutrition Reviews.2016; 74(10): 624.     CrossRef
    • Human gut microbiota and healthy aging: Recent developments and future prospective
      Manish Kumar, Parizad Babaei, Boyang Ji, Jens Nielsen
      Nutrition and Healthy Aging.2016; 4(1): 3.     CrossRef
    • The dormant blood microbiome in chronic, inflammatory diseases
      Marnie Potgieter, Janette Bester, Douglas B. Kell, Etheresia Pretorius, Prof. Antoine Danchin
      FEMS Microbiology Reviews.2015; 39(4): 567.     CrossRef
    • The C-terminal Domain Supports a Novel Function for CETPI as a New Plasma Lipopolysaccharide-Binding Protein
      Victor García-González, Nadia Gutiérrez-Quintanar, Jaime Mas-Oliva
      Scientific Reports.2015;[Epub]     CrossRef
    • Interactions between Autophagy and Bacterial Toxins: Targets for Therapy?
      Jacques Mathieu
      Toxins.2015; 7(8): 2918.     CrossRef
    • Calcitonin gene‐related peptide: key regulator of cutaneous immunity
      R. D. Granstein, J. A. Wagner, L. L. Stohl, W. Ding
      Acta Physiologica.2015; 213(3): 586.     CrossRef

    • PubReader PubReader
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Lipopolysaccharide: Basic Biochemistry, Intracellular Signaling, and Physiological Impacts in the Gut
      Intest Res. 2014;12(2):90-95.   Published online April 29, 2014
      Close
    • XML DownloadXML Download
    Figure
    • 0
    • 1
    • 2
    Lipopolysaccharide: Basic Biochemistry, Intracellular Signaling, and Physiological Impacts in the Gut
    Image Image Image
    Fig. 1 The Gram-negative bacterial envelope is composed of two bacterial membranes, outer and inner membrane. The outer membrane is enriched with lipopolysaccharide (LPS), which is an identifying feature of Gram-negative bacteria such as Escherichia coli. The lipid portion of the outer layer of the outer membrane is exclusively composed of LPS molecules. A single E. coli cell possesses approximately 2 million LPS molecules.
    Fig. 2 Chemical structure of the lipopolysaccharide (LPS) is presented. LPS consists of a polysaccharide, or long chain of sugar, and lipid A. The polysaccharide varies depending on bacterial species and is composed of O-specific chain (O-antigen) and two-part cores (Outer core and Inner core). Lipid A virtually includes two glucosamine sugars modified by phosphate and a variable number of fatty acids. It also has negatively charged phosphate groups.
    Fig. 3 Different molecular species of lipid A are observed in various pathogenic Gram-negative bacteria.
    Lipopolysaccharide: Basic Biochemistry, Intracellular Signaling, and Physiological Impacts in the Gut

    Intest Res : Intestinal Research
    Close layer
    TOP